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Abst rac t
Introduction: Chronic urticaria is a complex disease process in which chronic spontaneous urticaria (CSU) and chronic 
inducible urticaria are distinguished. Its etiopathogenesis still remains unknown. Some recent studies indicated a sig-
nificant participation of vitamin D in the etiopathogenesis of urticaria. In 40–50% of patients with CSU on the basis of 
the positive result of the autologous serum skin test (ASST), autoimmunological background of the disease is diagnosed. 
Moreover, numerous test results confirm involvement of the coagulation system/fibrinolysis and non-infectious inflam-
matory factors in the pathophysiology of CSU.
Aim: To determine whether some factors may play a role in pathogenesis and contribute to the severity of chronic 
spontaneous urticaria.
Material and methods: One hundred and forty-two patients with diagnosed CSU were enrolled in the study. The activity 
of urticaria was assessed using the UAS-7 (Urticaria Activity Score). The study participants were divided into 4 groups 
depending on the UAS-7. ASST was performed and blood was collected to determine the biomarkers (CRP, vitamin D, 
D-dimers, fibrinogen, MPV, PLT).
Results: Statistical analysis was performed using Statistica 13. A statistically significant difference between groups with 
various activity of urticaria in D-dimer concentration average values (p < 0.05) was observed. Moreover, a statistically 
significant negative correlation between activity of urticaria and vitamin D concentration (p < 0.001) was noted.
Conclusions: Our results might support the possible involvement of both coagulation and fibrinolysis pathway and vita-
min D in the urticaria pathomechanism. Further prospective studies in larger populations conducted at multiple centres 
are required to expand further our findings.
Key words: chronic urticaria, vitamin D, coagulation, fibrinolysis.
Introduction
Chronic urticaria is an etiopathologically complex 
disease process in which chronic spontaneous urticaria 
(CSU) and chronic inducible urticaria are distinguished 
[1–3].
Although about 2% of the European population suf-
fers from this disease, its etiopathogenesis still remains 
unknown [1, 3, 4]. There are some works indicating a sig-
nificant participation of vitamin D in the etiopathogen-
esis of urticaria. Furthermore, in 40–50% of patients with 
CSU on the basis of the positive result of the autologous 
serum skin test (ASST), an autoimmunological back-
ground of the disease is diagnosed [5, 6]. Moreover, nu-
merous test results confirm involvement of the coagula-
tion system/fibrinolysis and non-infectious inflammatory 
factor in the pathomechanism of CSU [1, 7–14]. 
Aim
The aim of the study was to determine whether C-
reactive protein (CRP), vitamin D, coagulation and fibri-
nolysis pathway as well as mean platelet volume (MPV) 
may play a role in pathogenesis and contribute to the 
severity of chronic spontaneous urticaria.
Material and methods
One hundred and forty-two patients (including 108 
women and 34 men) with CSU in the active phase at the 
age from 19 to 87 were qualified for the study. CSU di-
agnosis was based on the medical history and clinical 
picture of skin lesions. The active phase of the urticaria 
was defined as the presence of more than 5 hives that 
occurred within 7 days before the beginning of the study. 
What is more, all study participants were instructed not 
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to use any oral antihistamines, corticosteroids or anti-
thrombotic therapy for at least 2 weeks before the be-
ginning of the study. In each patient, on the basis of the 
results of consultations (dental, laryngological, urologi-
cal and gynaecological), the presence of latent inflam-
matory foci was excluded. On the basis of the imaging 
tests, thromboembolism of the lower limbs was excluded 
in patients with higher values of D-dimers.
The activity of urticaria was assessed using the UAS-
7 scale, assigning the obtained results to the following 
4 groups: urticaria with a minimal course 1–6, mild 7–15, 
medium 16–27 and severe 28–42, according to the guide-
lines of the EAACI/GA(2)LEN/EDF/WAO [15, 16]. ASST test 
was performed in all study participants. A venous blood 
sample from cubital fossa was taken for analysis of the 
following variables: complete blood count, electrolytes 
(Na, K), CRP, alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), creatinine, g-glutamyl transfer-
ase (GGTP), glomerular filtration rate (GFR), vitamin D, 
D-dimer and fibrinogen levels. 
Statistical analysis
Statistical analysis was based on the Statistica program 
(basic statistics, Student’s t-test, Mann-Whitney test, Spear-
man correlation, Anova test).
Results 
During the performed study, the average UAS-7 value 
in 142 subjects was 19.06. 
The mean values of UAS-7 in particular groups were 
distributed in the following way: group 1 – 4.11; group 2 
– 11.11; group 3 – 21.02; and group 4 – 32.36 (Figure 1). 
In the examined group, a statistically significant dif-
ference between groups with various activity of urticaria 
(defined as UAS-7 value) in D-dimer concentration aver-
age values (p < 0.05) was observed (Figure 2). We did 
not observe any statistically significant correlation be-
tween activity of urticaria (UAS-7 value) and fibrinogen 
as well as D-dimer concentration. However, a statistically 
significant negative correlation between activity of urti-
caria and vitamin D concentration (p < 0.001) was noted 
(Figure 3). 
Ninety-two (65%) study participants had positive 
ASST tests and 50 (35%) were ASST negative tested.
In the individuals with a positive ASST test, a statisti-
cally non-significant value of the UAS-7 scale (p = 0.58) 
and statistically non-significant higher vitamin D concen-
tration (p = 0.305) were found as compared to patients 
with a negative ASST result (Figures 4 and 5).
No significant correlation between the mean MPV 
values (p = 0.88816) and the PLT number (p = 0.935136) 
as well as the UAS-7 value in the examined groups was 
confirmed. 
In the examined material, no statistically significant 
increase (p = 0.16) in fibrinogen concentration with the 
increased activity of urticaria was observed (Figure 6). 
There was no statistically significant correlation be-
tween CRP concentration and activity of urticaria (p = 
0.14).
Figure 1. Distribution of the degree of activity of urticaria 
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Figure 2. D-dimer concentration in four groups in relation 
to the degree of urticaria activity
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Discussion
Our aim was to determine whether some factors may 
play a role in pathogenesis as well as contribute to the 
severity of CSU. We have noticed a statistically significant 
negative relationship between the urticaria active score 
(UAS) and serum level of vitamin D. We have observed 
the lowest serum level of vitamin D in patients from 
group 4 (with the highest UAS), which is consistent with 
the recent studies [17–20]. However, Thorp et al. have not 
observed a marked association between activity of urti-
caria and vitamin D serum level. On the basis of analysis 
of connections between D-dimer, fibrinogen concentra-
tion and UAS we have shown a significant difference 
between groups with various activity of urticaria in D-
dimer concentration average values. Moreover, we have 
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Figure 3. Vitamin D concentration in four groups in relation 
to the degree of urticaria activity
Figure 4. Activity of urticaria in the group of ASST positive 
and negative patients
Figure 5. Vitamin D concentration in the group of ASST 
positive and negative patients
UAS of a group; least squares means
Current effect: F(3.78) ± 1.7759, p = 0.15864
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Figure 6. Fibrinogen concentration in four groups in rela-
tion to the degree of urticaria activity
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score and fibrinogen as well as D-dimer serum level. 
Nonetheless, statistically significant relationships were 
not observed. Elevated D-dimer and fibrinogen plasma 
levels in patients with urticaria suggest activation of 
coagulation and fibrinolysis cascade. Our results are in 
line with other studies published recently [14, 21–23]. It 
is well-established that an increased fibrinogen and D-
dimer concentration without concomitant thrombosis is, 
as it has been observed in our present study, connected 
with activation of the coagulation and fibrinolysis path-
way. Such a condition is activated by chronic endothelial 
vasculitis during the active phase of urticaria and seems 
to be noteworthy [1, 14]. Taking into consideration previ-
ous studies, activation of the coagulation cascade result-
ing in the generation of thrombin, subsequently activates 
anti-coagulation and fibrinolysis. Thrombin and other 
proteins may play a key role in mast cell degranulation 
and result in urticaria. The exact mechanism how the 
coagulation, anti-coagulation, fibrinolysis and comple-
ment systems act in CSU pathogenesis is required to be 
expanded further in future studies [21–23].
Our results regarding a possible relationship between 
an inflammation biomarker like CRP and UAS are partly 
consistent with the recent data [14, 15, 21, 24, 25]. Ad-
ditionally, in our study we have noticed that CRP tends 
to have higher values (without any inflammation points 
in routine imaging like abdominal ultrasonography and 
chest X-ray) in the relation to the severity of urticaria 
in groups 1–3 of UAS score. The interpretation of such 
a finding has been a subject of the debate in many stud-
ies published recently, and might be connected with an 
increased activity of mast cells in urticaria [8, 21]. How-
ever, our study might indicate that CRP increase without 
any present inflammation might be a symptom of ac-
tive endothelial vasculitis with the forced permeability 
[14]. It is interesting to note that among patients with 
a severe form of urticaria we have found an increased 
fibrinogen and D-dimer concentration concomitant with 
the decrease of CRP values. This outcome seems to be 
worth considering. It might indicate that in pathogenesis 
of the severe form of urticaria, coagulation and fibrino-
lysis pathway play a greater role than inflammatory dis-
order like endothelial vasculitis [14, 26, 27]. According to 
the available data, chronic spontaneous urticaria has an 
autoimmunological character in over 40–50% of cases 
[5, 6]. In the present study we have analysed vitamin D 
concentration and UAS among patients with both nega-
tive and positive ASST, which is known as an indicator 
of chronic autoimmune urticaria. Interestingly, we have 
shown that the vitamin D serum level was not statisti-
cally significantly higher among ASST positive patients in 
a comparison with ASST negative patients. This result is 
not consistent with previous data of other authors where 
there was no relationship between the parameters or, 
on the other hand, a statistically significant association 
was observed [17, 28]. ASST positive patients presented 
a more severe form of urticaria as they had higher UAS-7 
values than ASST negative patients. That observation is 
in line with previously described results [21, 29, 30]. 
Our results could not confirm the theory that patients 
with a low vitamin D serum level are predisposed to the 
development of autoimmune urticaria. However, a series 
of studies previously reported reduction of urticaria se-
verity due to vitamin D supplementation among ASST 
positive patients. These results might directly support 
the involvement of vitamin D in the immune system [17, 
31–33]. Interestingly, Chen et al. in their study showed 
that vitamin D inhibits plasma B cells differentiation 
which also results in suppressing of antibodies secretion 
[18]. This effect seems to be depending on the number 
of receptors for vitamin D on lymphocytes B, and, what 
is more, might be concomitant with an increased activ-
ity of previously existing lymphocytes B. This condition 
might clarify our finding regarding a lower vitamin D 
level among patients with positive ASST in compari-
son with ASST negative patients. Furthermore, we have 
analysed the association between urticaria activity and 
MPV. Obtained results were not statistically significant 
corresponding with outcomes of Nishimura et al. [34]. 
However, in some previous studies this relationship was 
established, which leaves that matter intriguing [35, 36]. 
We also have assayed a possible connection between 
platelet count and severity of urticaria, but no results 
worth considering were found. In conclusion, in the pres-
ent study we have observed a statistically significant cor-
relation between urticaria activity and vitamin D as well 
as a statistically significant difference between groups 
with various activity of urticaria in D-dimer concentration 
average values. These results might directly support the 
possible involvement of both coagulation and fibrinolysis 
pathway and vitamin D in the urticaria pathomechanism 
and open new perspectives for a better understanding 
of the pathogenesis as well as the treatment of the dis-
ease. Moreover, our study may in some measure suggest 
that an increased D-dimer level in patients with severe 
urticaria should be considered not only as an indicator 
of its activity. A series of studies previously showed that 
the elevated D-dimer serum concentration may be re-
garded as a useful biomarker of worse response to stan-
dard treatment by antihistaminic drugs or cyclosporines 
[7, 37]. Unquestionably, further prospective studies with 
evaluation of response to the standard treatment in pa-
tients with an increased D-dimer level in larger popula-
tions conducted at multiple centres are required to ex-
pand further our findings.
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